Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout sheeba farhat9 Jan 2026 2:53 PM ISTThis is Lilly's first major transaction of 2026, following a year when its market value topped USD 1 trillion on surging sales of GLP-1 drugs...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs sheeba farhat7 Jan 2026 4:11 PM ISTNimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to develop an easy-to-take oral...
Tirzepatide may only temporarily suppress brain activity involved in "food noise", suggests study Dr. Kamal Kant Kohli24 Nov 2025 9:00 PM ISTA rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, ...
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom Ruchika Sharma22 Nov 2025 5:49 PM ISTBengaluru: Eli Lilly just hit a USD 1 trillion in market value, becoming the first-ever pharmaceutical company to join the exclusive...
Biocon targets launch for generic Wegovy in India by 2027 Ruchika Sharma17 July 2025 5:20 PM ISTBiopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster weight-loss drug Wegovy in India by...
WHO to back use of weight-loss drugs as obesity treatment in adults Ruchika Sharma5 May 2025 11:00 AM ISTLondon: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity in adults for the...
Sun Pharma eyes to launch obesity drug in five years: MD Ruchika Sharma1 March 2025 2:34 PM ISTMumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes medicine in the next...
Copycat weight-loss drugs: Eli Lilly sues two medical spas Ruchika Sharma14 Jan 2025 5:28 PM ISTTwo medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
USFDA approves Eli Lilly weight loss treatment Zepbound for obstructive sleep apnea Ruchika Sharma21 Dec 2024 1:30 PM ISTstyle="text-align: justify; ">Indianapolis: Eli Lilly and Company has announced the U.S. Food and Drug Administration (FDA) has...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production MD Bureau Team15 Sept 2024 9:00 AM ISTLondon: Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and...
